๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Egyptian Hypertrophic Cardiomyopathy Program

Recruitingn/aAges any - anyAllMagdi Yacoub Heart Foundation
NCT05884892 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry. * All family members of index patients who are willing and consented to participate in the registry. Exclusion Criteria: * Refusal to consent to participate in the registry program.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Aswan Heart Centre - Magdi Yacoub Heart Foundation
Aswฤn, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy